January 22, 2024 Comments Off on Legislative Proposals to Tackle Improper Pharmaceutical Patents in the Orange Book Posted in: Insights A recent article published in Health Affairs, delves into the Federal Trade Commission’s (FTC) concerns regarding the inclusion of improper patents in the FDA’s Orange Book by pharmaceutical manufacturers. The…
The post Legislative Proposals to Tackle …
January 22, 2024 Comments Off on New patent expiration for Mayne Pharma drug RHOFADE Posted in: Uncategorized
Annual Drug Patent Expirations for RHOFADE Rhofade is a drug marketed by Mayne Pharma and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Mayne Pharma drug RHOFADE appeared first on…
